Literature DB >> 12130743

Chronic morphine-induced changes in mu-opioid receptors and G proteins of different subcellular loci in rat brain.

G Fábián1, B Bozó, M Szikszay, G Horváth, C J Coscia, M Szücs.   

Abstract

Prolonged exposure to opioid agonists can induce adaptive changes resulting in tolerance and dependence. Here, rats were rendered tolerant by subcutaneous injections of increasing doses of morphine from 10 to 60 mg/kg for 3, 5, or 10 consecutive days. Binding parameters of the mu-opioid receptor in subcellular fractions were measured with [(3)H]DAMGO ([D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin). Although the density of surface mu-sites did not change after the 5-day morphine treatment, up-regulation of synaptic plasma membrane binding was detected after the 10-day drug administration. In contrast, the number of mu-binding sites in a light vesicle or microsomal fraction (MI) was elevated by 68 and 30% after 5 and 10 days of morphine exposure, respectively. The up-regulated MI mu-sites displayed enhanced coupling to G proteins compared with those detected in saline-treated controls. Pertussis toxin catalyzed ADP ribosylation, and Western blotting with specific antisera was used to quantitate chronic morphine-induced changes in levels of various G protein alpha-subunits. Morphine treatment of 5 days and longer induced significant increases in levels of Galpha(o), Galpha(i1), and Galpha(i2) in MI fractions that are part of an adaptation process. Up-regulation of intracellular mu-sites may be the result of post-translational changes and in part de novo synthesis. The results provide the first evidence that distinct regulation of intracellular mu-opioid receptor G protein coupling and G protein levels may accompany the development of morphine tolerance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12130743     DOI: 10.1124/jpet.102.036152

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

1.  Up-regulation of mu-opioid receptors in the spinal cord of morphine-tolerant rats.

Authors:  Subrata Basu Ray; Himanshu Gupta; Yogendra Kumar Gupta
Journal:  J Biosci       Date:  2004-03       Impact factor: 1.826

2.  Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.

Authors:  Judit Oláh; Orsolya Vincze; Dezsõ Virók; Dóra Simon; Zsolt Bozsó; Natália Tõkési; István Horváth; Emma Hlavanda; János Kovács; Anna Magyar; Mária Szũcs; Ferenc Orosz; Botond Penke; Judit Ovádi
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

3.  Disruption of morphine-conditioned place preference by a delta2-opioid receptor antagonist: study of mu-opioid and delta-opioid receptor expression at the synapse.

Authors:  Sophie K Billa; Yan Xia; Jose A Morón
Journal:  Eur J Neurosci       Date:  2010-07-09       Impact factor: 3.386

4.  Chronic and intermittent morphine treatment differently regulates opioid and dopamine systems: a role in locomotor sensitization.

Authors:  Thierry Le Marec; Cynthia Marie-Claire; Florence Noble; Nicolas Marie
Journal:  Psychopharmacology (Berl)       Date:  2011-02-22       Impact factor: 4.530

5.  The interaction between the mu opioid receptor and filamin A.

Authors:  Eric J Simon; Irma Onoprishvili
Journal:  Neurochem Res       Date:  2010-09-21       Impact factor: 3.996

6.  Thalidomide Promotes Morphine Efficacy and Prevents Morphine-Induced Tolerance in Rats with Diabetic Neuropathy.

Authors:  Jianhui Zhao; Hong Wang; Tieying Song; Yunliang Yang; Kunfeng Gu; Pengyu Ma; Zaiwang Zhang; Limin Shen; Jiabao Liu; Wenli Wang
Journal:  Neurochem Res       Date:  2016-08-30       Impact factor: 3.996

7.  Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A.

Authors:  Irma Onoprishvili; Eric J Simon
Journal:  Brain Res       Date:  2007-08-16       Impact factor: 3.252

8.  Regulation of an Opioid Receptor Chaperone Protein, RTP4, by Morphine.

Authors:  Wakako Fujita; Mini Yokote; Ivone Gomes; Achla Gupta; Hiroshi Ueda; Lakshmi A Devi
Journal:  Mol Pharmacol       Date:  2018-10-22       Impact factor: 4.436

9.  Soluble epoxide hydrolase inhibitor mediated analgesia lacks tolerance in rat models.

Authors:  Karen M Wagner; Jogen Atone; Bruce D Hammock
Journal:  Brain Res       Date:  2019-11-29       Impact factor: 3.252

10.  Role of the guanine nucleotide binding protein, Gαo, in the development of morphine tolerance and dependence.

Authors:  Jennifer T Lamberts; Lisa D Rosenthal; Emily M Jutkiewicz; John R Traynor
Journal:  Psychopharmacology (Berl)       Date:  2017-10-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.